These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 23109704)
81. Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes? Meindl A Breast Care (Basel); 2009; 4(2):93-99. PubMed ID: 21049069 [TBL] [Abstract][Full Text] [Related]
82. The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer. Ambrosone CB Breast Cancer Res; 2007; 9(6):114. PubMed ID: 18096087 [TBL] [Abstract][Full Text] [Related]
83. Breast Cancer-Related Low Penetrance Genes. Kang D; Choi JY Adv Exp Med Biol; 2021; 1187():419-434. PubMed ID: 33983592 [TBL] [Abstract][Full Text] [Related]
84. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Fahed AC; Wang M; Homburger JR; Patel AP; Bick AG; Neben CL; Lai C; Brockman D; Philippakis A; Ellinor PT; Cassa CA; Lebo M; Ng K; Lander ES; Zhou AY; Kathiresan S; Khera AV Nat Commun; 2020 Aug; 11(1):3635. PubMed ID: 32820175 [TBL] [Abstract][Full Text] [Related]
85. Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years. Plym A; Zhang Y; Stopsack KH; Jee YH; Wiklund F; Kibel AS; Kraft P; Giovannucci E; Penney KL; Mucci LA Clin Cancer Res; 2022 Nov; 28(22):4926-4933. PubMed ID: 36103261 [TBL] [Abstract][Full Text] [Related]
87. Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer. Willoughby A; Andreassen PR; Toland AE J Pers Med; 2019 Mar; 9(1):. PubMed ID: 30832243 [TBL] [Abstract][Full Text] [Related]
88. Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases. Dudbridge F; Fletcher O; Walker K; Johnson N; Orr N; Dos Santos Silva I; Peto J Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):262-72. PubMed ID: 22028405 [TBL] [Abstract][Full Text] [Related]
90. New cancer susceptibility loci: population and familial risks. Hemminki K; Försti A; Lorenzo Bermejo J Int J Cancer; 2008 Oct; 123(7):1726-9. PubMed ID: 18623115 [TBL] [Abstract][Full Text] [Related]
91. Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer. Wong EM; Southey MC; Terry MB Br J Cancer; 2020 Apr; 122(8):1133-1140. PubMed ID: 32066913 [TBL] [Abstract][Full Text] [Related]
92. Polygenic Contribution in Individuals With Early-Onset Coronary Artery Disease. Thériault S; Lali R; Chong M; Velianou JL; Natarajan MK; Paré G Circ Genom Precis Med; 2018 Jan; 11(1):e001849. PubMed ID: 29874178 [TBL] [Abstract][Full Text] [Related]
93. Familial breast cancer. Part III: Genome instability and cancer risk. Nacheva M; Gavrilov I; Tzingilev D J BUON; 2002; 7(2):149-52. PubMed ID: 17577280 [TBL] [Abstract][Full Text] [Related]
94. Communicating polygenic risk scores in the familial breast cancer clinic. Das Gupta K; Gregory G; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; McInerney-Leo A; Young MA; James PA; Yanes T Patient Educ Couns; 2021 Oct; 104(10):2512-2521. PubMed ID: 33706980 [TBL] [Abstract][Full Text] [Related]
95. Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior. Yanes T; Meiser B; Kaur R; Young MA; Mitchell PB; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Betz-Stablein B; James PA Genet Med; 2021 Dec; 23(12):2316-2323. PubMed ID: 34341522 [TBL] [Abstract][Full Text] [Related]
96. Transmission of breast cancer polygenic risk based on single nucleotide polymorphisms. Cox DG; Heudel PE; Henry J; Pivot X Breast; 2018 Oct; 41():14-18. PubMed ID: 29933179 [TBL] [Abstract][Full Text] [Related]
97. Genomic Risk Prediction for Breast Cancer in Older Women. Lacaze P; Bakshi A; Riaz M; Orchard SG; Tiller J; Neumann JT; Carr PR; Joshi AD; Cao Y; Warner ET; Manning A; Nguyen-Dumont T; Southey MC; Milne RL; Ford L; Sebra R; Schadt E; Gately L; Gibbs P; Thompson BA; Macrae FA; James P; Winship I; McLean C; Zalcberg JR; Woods RL; Chan AT; Murray AM; McNeil JJ Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298747 [TBL] [Abstract][Full Text] [Related]
98. Polygenic susceptibility to breast cancer: current state-of-the-art. Ghoussaini M; Pharoah PD Future Oncol; 2009 Jun; 5(5):689-701. PubMed ID: 19519208 [TBL] [Abstract][Full Text] [Related]
99. Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk. Gregory G; Das Gupta K; Meiser B; Barlow-Stewart K; Geelan-Small P; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Antill Y; Salmon L; Smyth C; Young MA; James PA; Yanes T J Genet Couns; 2022 Feb; 31(1):120-129. PubMed ID: 34223688 [TBL] [Abstract][Full Text] [Related]
100. Towards a more precise and individualized assessment of breast cancer risk. Wood ME; Farina NH; Ahern TP; Cuke ME; Stein JL; Stein GS; Lian JB Aging (Albany NY); 2019 Feb; 11(4):1305-1316. PubMed ID: 30787204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]